Carbohydrates
We seek customers, commercialisation partners and researchers/clinicians interested in our broad range of carbohydrate-based products.
IN-LICENSING
Our company is actively seeking strategic business development and licensing opportunities that align with our commitment to enhancing patient care through innovative therapies.
We are focused on expanding our portfolio within the fields of non-malignant haematology and oncology supportive care, prioritising opportunities that offer global rights, US rights or regional rights for Europe or China.
Additionally, we are open to opportunities within hospital-administered products across various specialties, including gastroenterology, obstetrics and gynaecology, surgery, cardiovascular diseases and nephrology (excluding dialysis).
To learn more, please contact at info@pharmacosmos.com
OUT-LICENSING
It’s vital that partners allocate adequate dedicated resources specifically to the Monofer® business. Additionally, having an established presence in relevant medical specialties such as haematology, gastroenterology, nephrology, gynecology/obstetrics, surgery and cardiovascular is essential.
Potential partners should be competent in marketing ethical pharmaceutical products, be ready to handle the complexities of intravenous pharmaceuticals, have hospital training capabilities and post-implementation expertise, have strong competences in collaborating with key opinion leaders, and have the financial capability to succeed with Monofer®.
If you are interested in a partnership, we would need an overview of your current market activities and capabilities in relation to intravenous iron, details of your therapeutic area coverage, other brands in your portfolio, and general company information, to assess our potential collaboration.
COLLABORATION WITH RESEARCHERS & CLINICIANS
We collaborate with leading medical experts in driving research to uncover new clinical insights of iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans. We are actively seeking opportunities to support investigator-sponsored studies.
To learn more, please contact Lars L. Thomsen at info@pharmacosmos.com
PHARMACOSMOS IST ...
Ein globaler Pionier in der Kohlenhydratchemie und ein führendes Unternehmen in der Entwicklung innovativer Behandlungen für Patienten, die an Eisenmangel und Eisenmangelanämie leiden.
